Journal article
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer.
Abstract
76
Background: In recent years, treatment intensification beyond androgen deprivation therapy (ADT) with several novel therapies have shown survival benefit in patients with metastatic castration-sensitive prostate cancer (mCSPC). Given the rapidly evolving landscape in mCSPC treatment, there is a need to better understand how treatment strategies fit in real-world clinical practice and are combined/sequenced with other …
Authors
Gotto GT; Yip SM; Shayegan B; O'Sullivan DE; Wallis CJD; Basappa NS; Cagiannos I; Hamilton RJ; Ferrario C; Fernandes R
Journal
Journal of Clinical Oncology, Vol. 41, No. 6_suppl, pp. 76–76
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 20, 2023
DOI
10.1200/jco.2023.41.6_suppl.76
ISSN
0732-183X